Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
May 09 2024 - 10:00AM
Science 37 Holdings, Inc., today announced its selection as winner
of the “Clinical Efficiency Innovation Award” in the 8th annual
MedTech Breakthrough Awards program.
MedTech Breakthrough, an independent market intelligence
organization, recognized Science 37 for its transformative solution
to clinical research patient recruitment. By leveraging its
nationwide medical licensure and AI-powered patient screening
capabilities, Science 37’s Patient Recruitment solution engages,
medically qualifies, and delivers fully consented participants to
sites prior to their first study visit. This unique approach
creates a better patient experience, increases patient
randomization rates, improves site satisfaction, and nearly
eliminates patients being redirected to competing studies.
“We understand the difficulty in turning referrals into
consented participants and have worked hard to address these issues
by revolutionizing the conventional approaches head-on,” said Erica
Prowisor, SVP Patient and Site Networks at Science 37. “This award
from MedTech Breakthrough highlights our work to mitigate the core
challenges of conventional recruitment methods resulting in a
win-win for sponsors and sites. We’ll continue to transform patient
recruitment by delivering an improved process designed to increase
enrollment and site/primary investigator productivity.”
The mission of the MedTech Breakthrough Awards is to honor
excellence and recognize the innovation, hard work and success in a
range of health and medical technology categories, including
Telehealth, Clinical Administration, Patient Engagement, Electronic
Health Records (EHR), Virtual Care, Medical Devices, Medical Data
& Privacy, and many more. This year’s program attracted
thousands of nominations from over 18 different countries
throughout the world.
“The ability to find, recruit, and enroll participants is a huge
challenge for clinical trials, resulting in 80% of them being
delayed, and the majority of participant referrals are not even
fully qualified,” said Steve Johansson, Managing Director at
MedTech Breakthrough. “By delivering fully consented and medically
qualified participants directly to sites, sponsors, and CROs,
Science 37 eliminates common issues of disengaged site staff and
having referrals diverted to competing studies. Science 37's
Patient Recruitment is more than a solution—it's a leap forward in
clinical trial efficiency and innovation—and we’re thrilled to
recognize the entire Science 37 team for taking home our ‘Clinical
Efficiency Innovation Award’ in 2024.”
About MedTech BreakthroughPart of Tech
Breakthrough, a leading market intelligence and recognition
platform for global technology innovation and leadership, the
MedTech Breakthrough Awards program is devoted to honoring
excellence and innovation in medical & health technology
companies, products, services and people. The MedTech Breakthrough
Awards provide a platform for public recognition around the
achievements of breakthrough healthcare and medical companies and
products in categories that include Patient Experience &
Engagement, Health & Fitness, Medical Devices, Clinical
Administration, Connected Healthcare, Medical Data, Healthcare
Cybersecurity and more. For more information
visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or
service depicted in our recognition programs, and does not advise
technology users to select only those vendors with award
designations. Tech Breakthrough LLC recognition consists of the
opinions of the Tech Breakthrough LLC organization and should not
be construed as statements of fact. Tech Breakthrough LLC disclaims
all warranties, expressed or implied, with respect to this
recognition program, including any warranties of merchantability or
fitness for a particular purpose.
About Science 37
Science 37’s mission is to accelerate clinical research by
enabling universal trial access for patients. Through our
solutions; the Metasite™ and Patient Recruitment, we accelerate
enrollment by expanding the reach of clinical trials to patients
beyond the traditional site and rigorously qualifying patients
prior to referring them to a traditional site. Our solutions are
powered by a proprietary technology stack with in-house medical and
operational experts that enhance quality through standardized
workflows and best-in-class study orchestration. To learn more,
visit www.science37.com, or email science37@science37.com.
To view studies that Science 37 is actively recruiting for,
please visit https://studies.science37.com/current-studies/.
Media InquiriesScience
37PR@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jul 2024 to Aug 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Aug 2023 to Aug 2024